Ma, L., Dong, J., Li, Y., Zhang, X., Li, Z., Chen, H., . . . Ji, Z. (2025). Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationMa, Lin, et al. Malevolent Alliance of MYBL2hi Cancer Stem Cell and SPP1+ Macrophage Confers Resistance to Neoadjuvant Immunotherapy in Bladder Cancer. BMJ Publishing Group, 2025.
MLA (9th ed.) CitationMa, Lin, et al. Malevolent Alliance of MYBL2hi Cancer Stem Cell and SPP1+ Macrophage Confers Resistance to Neoadjuvant Immunotherapy in Bladder Cancer. BMJ Publishing Group, 2025.
Warning: These citations may not always be 100% accurate.